A Phase 2 Study of MEDI4736(durvalumab) and Tremelimumab Alone or in Combination with High or Low-Dose Radiation in Metastatic Colorectal and NSCLC

IRB/UVA Tracking #
20067
Contact
Gracie Tubbs Hockenberry
Contact Email
Contact Phone
+1 .434.4-29
Phase
II
Primary purpose
Treatment
Cancer PI
Ryan Gentzler
Status
OPEN TO ACCRUAL